SEC Form 4 · accession 0001193125-26-263997
GLOBUS MEDICAL INC · GMED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David D Davidar
Director
Period of report
Jun 5, 2026
Accepted (ET)
Jun 9, 2026 · 5:04 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001237831
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jun 5, 2026 | M | 25,000 | $26.27 | A | 535,175 | D | |
| Class A Common StockF1 | Jun 5, 2026 | S | 25,000 | $80.7629 | D | 510,175 | D | |
| Class A Common StockF2 | holding | — | — | — | 165,967 | I | By Davidar Family Irrevocable Trust U/A 8/6/09 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F3 | $26.27 | Jun 5, 2026 | M | 25,000 | D | — | Jan 30, 2027 | Class A Common Stock | 25,000 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at a price range of $80.59 - $80.92, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (1) of this Form 4.
- F2These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is trustee of the trust.
- F3These options were granted on January 30, 2017 and are fully vested.